Investing Profile

Stephen Squinto

InvestorVC
Executive Partner at Orbimed
orbimed.comNew York, New York
Photo of Stephen Squinto, Partner at OrbiMed
Your Intro Paths to Stephen Squinto

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Stephen Squinto on

cb
Current Investing Position
OrbiMed Partner
Investment Range
$1M - $75.0M
Sweet Spot
$4.0M
Investments On Record
18
Current Fund Size
$18B

Stephen Squinto is on these Sector & Stage Rankings

Stephen Squinto's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
Enlaza Therapeutics
Series AApr 2024$100M
$160M
Co-investors: James N. Topper (Frazier Healthcare Partners), Marcos Milla (Samsara BioCapital), Jay Lichter (Avalon Ventures)
Vanqua Bio
Series BSep 2021$85M
$85M
Co-investors: Jonathan Silverstein (OrbiMed), Bernard Davitian (Omega Funds), Mona Ashiya (OrbiMed Advisors), Sara Nayeem (Avoro Ventures)
iECURE
Series ASep 2021$50M
$120M
Co-investors: Tom Woiwode (Versant Ventures)
Gennao Bio
Series AMay 2021$40M
$40M
Co-investors: Chau Khuong (OrbiMed)
Chemomab
Post Ipo EquityMar 2021$46M
$56M
Co-investors: Peter Thiel (Founders Fund)
Gemini Therapeutics
Post Ipo EquityFeb 2021$95M
Series AOct 2017$43M
SeedApr 2016$2M
$140M
Co-investors: Jason Rhodes (Atlas Venture), Carl Gordon (OrbiMed Advisors), Jean George (Advanced Technology Ventures)
Compass Therapeutics
Series UnknownJul 2020$60M
$160M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Peter Thiel (Founders Fund), George Godula (Life Biosciences), Ben Auspitz (Forge Life Science Partners), Phil Ferneau (Borealis Ventures), Carl Gordon (OrbiMed Advisors), Julie Sunderland (Biomatics Capital Partners)
Passage Bio
Series AFeb 2019$120M
$230M
Co-investors: Liam Ratcliffe (Access Biotechnology), Patrick Heron (Frazier Healthcare Partners), Carl Gordon (OrbiMed Advisors), Tom Woiwode (Versant Ventures)